Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02363686 · ClinicalTrials.gov registry record · NA

Aspiration in Acute Respiratory Failure Survivors

A NA study of Dysphagia, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
248
Enrollment target
3
Study locations

NCT02363686 is a NA study of Dysphagia that has completed, run by University of Colorado, Denver. The registered enrollment target is 248 participants, above the 165-participant average among 35 other Dysphagia trials with a reported enrollment target (50% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02363686, a NA study of Dysphagia, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
248 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe.

Conditions Studied

Interventions

  • PROCEDURE FEES
  • PROCEDURE BSE

Study Locations (3)

Colorado

  • University of Colorado Hospital - Aurora

Connecticut

  • Yale University - New Haven

Massachusetts

  • Boston University Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2012-02
Est. Completion 2020-11-30
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02363686

The ClinicalTrials.gov registry entry for NCT02363686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 165-participant average among 35 other Dysphagia trials with a reported enrollment target (50% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dysphagia appearing as the primary indexed condition, and to 2 interventions - of which FEES is the first listed.

NCT02363686 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Connecticut, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02363686 about?

NCT02363686 is a clinical study titled "Aspiration in Acute Respiratory Failure Survivors". The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe.

What is the current status of trial NCT02363686?

This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2012-02. Estimated completion is 2020-11-30.

What conditions does trial NCT02363686 study?

This clinical trial studies the following conditions: Dysphagia.

What interventions are being tested in trial NCT02363686?

The interventions under investigation include: FEES (PROCEDURE), BSE (PROCEDURE).

Who is sponsoring clinical trial NCT02363686?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02363686 being conducted?

This trial has 3 study locations across Colorado, Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dysphagia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.